Invesco’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36.4M Sell
289,245
-278,075
-49% -$35M 0.01% 1190
2025
Q1
$62.7M Sell
567,320
-382,192
-40% -$42.3M 0.01% 948
2024
Q4
$130M Buy
949,512
+74,847
+9% +$10.2M 0.02% 734
2024
Q3
$101M Sell
874,665
-383,439
-30% -$44.2M 0.02% 796
2024
Q2
$173M Buy
1,258,104
+121,162
+11% +$16.7M 0.04% 609
2024
Q1
$157M Buy
1,136,942
+463,134
+69% +$63.9M 0.03% 662
2023
Q4
$88.8M Buy
673,808
+287,693
+75% +$37.9M 0.02% 795
2023
Q3
$43.4M Sell
386,115
-176,245
-31% -$19.8M 0.01% 1019
2023
Q2
$53M Sell
562,360
-13,914
-2% -$1.31M 0.01% 923
2023
Q1
$58.3M Sell
576,274
-851,005
-60% -$86.1M 0.02% 884
2022
Q4
$170M Buy
1,427,279
+521,568
+58% +$62.3M 0.05% 525
2022
Q3
$96.2M Buy
905,711
+635,394
+235% +$67.5M 0.03% 678
2022
Q2
$26.4M Buy
270,317
+18,452
+7% +$1.8M 0.01% 1215
2022
Q1
$23.6M Sell
251,865
-29,253
-10% -$2.74M 0.01% 1406
2021
Q4
$23.9M Sell
281,118
-46,693
-14% -$3.98M 0.01% 1442
2021
Q3
$31.4M Sell
327,811
-766,088
-70% -$73.5M 0.01% 1272
2021
Q2
$106M Buy
1,093,899
+6,534
+0.6% +$636K 0.03% 813
2021
Q1
$106M Buy
1,087,365
+4,224
+0.4% +$411K 0.03% 773
2020
Q4
$104M Sell
1,083,141
-650,332
-38% -$62.3M 0.03% 710
2020
Q3
$167M Sell
1,733,473
-219,836
-11% -$21.1M 0.06% 424
2020
Q2
$238M Buy
1,953,309
+959,127
+96% +$117M 0.09% 278
2020
Q1
$86M Sell
994,182
-124,255
-11% -$10.8M 0.04% 562
2019
Q4
$120M Sell
1,118,437
-204,879
-15% -$22M 0.04% 578
2019
Q3
$119M Buy
1,323,316
+45,004
+4% +$4.06M 0.03% 595
2019
Q2
$108M Sell
1,278,312
-644,606
-34% -$54.4M 0.03% 649
2019
Q1
$169M Sell
1,922,918
-205,944
-10% -$18.1M 0.06% 379
2018
Q4
$152M Sell
2,128,862
-4,180
-0.2% -$298K 0.06% 361
2018
Q3
$262M Buy
2,133,042
+58,489
+3% +$7.19M 0.08% 255
2018
Q2
$204M Sell
2,074,553
-297,902
-13% -$29.3M 0.07% 317
2018
Q1
$197M Sell
2,372,455
-352,969
-13% -$29.3M 0.07% 286
2017
Q4
$211M Sell
2,725,424
-224,444
-8% -$17.4M 0.08% 288
2017
Q3
$181M Sell
2,949,868
-6,720
-0.2% -$412K 0.07% 325
2017
Q2
$136M Buy
2,956,588
+235,524
+9% +$10.8M 0.04% 405
2017
Q1
$118M Sell
2,721,064
-60,359
-2% -$2.61M 0.04% 448
2016
Q4
$108M Buy
2,781,423
+184,782
+7% +$7.15M 0.04% 481
2016
Q3
$131M Buy
2,596,641
+992,680
+62% +$50.3M 0.05% 418
2016
Q2
$72.9M Sell
1,603,961
-778,940
-33% -$35.4M 0.03% 600
2016
Q1
$94.2M Buy
2,382,901
+435,270
+22% +$17.2M 0.04% 524
2015
Q4
$110M Sell
1,947,631
-236,689
-11% -$13.4M 0.04% 464
2015
Q3
$86.9M Buy
2,184,320
+118,246
+6% +$4.71M 0.04% 527
2015
Q2
$98.7M Buy
2,066,074
+228,248
+12% +$10.9M 0.04% 515
2015
Q1
$73M Buy
1,837,826
+1,686,656
+1,116% +$67M 0.03% 631
2014
Q4
$3.38M Buy
151,170
+150,480
+21,809% +$3.36M ﹤0.01% 2185
2014
Q3
$11K Buy
690
+3
+0.4% +$48 ﹤0.01% 4022
2014
Q2
$10K Hold
687
﹤0.01% 4014
2014
Q1
$11K Sell
687
-813,369
-100% -$13M ﹤0.01% 4026
2013
Q4
$7.6M Buy
814,056
+423,110
+108% +$3.95M ﹤0.01% 1727
2013
Q3
$4.43M Sell
390,946
-214
-0.1% -$2.42K ﹤0.01% 2013
2013
Q2
$5.23M Buy
+391,160
New +$5.23M ﹤0.01% 1820